IL150179A0 - Cyclic quaternary ammonium compounds - Google Patents

Cyclic quaternary ammonium compounds

Info

Publication number
IL150179A0
IL150179A0 IL15017900A IL15017900A IL150179A0 IL 150179 A0 IL150179 A0 IL 150179A0 IL 15017900 A IL15017900 A IL 15017900A IL 15017900 A IL15017900 A IL 15017900A IL 150179 A0 IL150179 A0 IL 150179A0
Authority
IL
Israel
Prior art keywords
quaternary ammonium
ammonium compounds
cyclic quaternary
cyclic
compounds
Prior art date
Application number
IL15017900A
Other languages
English (en)
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of IL150179A0 publication Critical patent/IL150179A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL15017900A 1999-12-15 2000-12-15 Cyclic quaternary ammonium compounds IL150179A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292351 1999-12-15
PCT/CA2000/001506 WO2001044192A1 (en) 1999-12-15 2000-12-15 Cyclic quaternary ammonium compounds

Publications (1)

Publication Number Publication Date
IL150179A0 true IL150179A0 (en) 2002-12-01

Family

ID=4164887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15017900A IL150179A0 (en) 1999-12-15 2000-12-15 Cyclic quaternary ammonium compounds

Country Status (19)

Country Link
US (1) US20030166629A1 (pl)
EP (1) EP1278731A1 (pl)
JP (1) JP2003516966A (pl)
KR (1) KR20020074170A (pl)
CN (1) CN1425005A (pl)
AU (1) AU2334501A (pl)
BG (1) BG106816A (pl)
BR (1) BR0016431A (pl)
CZ (1) CZ20022095A3 (pl)
EE (1) EE200200314A (pl)
HU (1) HUP0301686A2 (pl)
IL (1) IL150179A0 (pl)
IS (1) IS6417A (pl)
MX (1) MXPA02006051A (pl)
NO (1) NO20022870L (pl)
PL (1) PL356032A1 (pl)
WO (1) WO2001044192A1 (pl)
YU (1) YU44102A (pl)
ZA (1) ZA200205566B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090082507A (ko) 2006-11-20 2009-07-30 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 통증 및 소양증 치료용 방법, 조성물 및 키트
CN102112121A (zh) * 2008-03-11 2011-06-29 哈佛大学校长及研究员协会 用于治疗疼痛和瘙痒的方法、组合物和药盒
WO2011006073A1 (en) 2009-07-10 2011-01-13 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
US10130632B2 (en) 2012-11-27 2018-11-20 Beth Israel Deaconess Medical Center, Inc. Methods for treating renal disease
WO2015120069A1 (en) 2014-02-04 2015-08-13 Beth Israel Deaconess Medical Center, Inc. Methods and kits for the diagnosis and treatment of pancreatic cancer
US11021443B2 (en) * 2015-08-03 2021-06-01 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
CN113811305A (zh) 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3155568A1 (en) 2019-11-06 2021-05-14 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
AU2020380118B2 (en) 2019-11-06 2026-06-11 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI58632C (fi) * 1978-02-07 1981-03-10 Orion Yhtymae Oy Foerfarande foer framstaellning av anilider med antitussiv verkan

Also Published As

Publication number Publication date
MXPA02006051A (es) 2004-08-23
CN1425005A (zh) 2003-06-18
KR20020074170A (ko) 2002-09-28
NO20022870L (no) 2002-08-14
ZA200205566B (en) 2003-11-17
YU44102A (sh) 2005-09-19
EP1278731A1 (en) 2003-01-29
AU2334501A (en) 2001-06-25
CZ20022095A3 (cs) 2003-02-12
JP2003516966A (ja) 2003-05-20
BR0016431A (pt) 2002-10-01
WO2001044192A1 (en) 2001-06-21
US20030166629A1 (en) 2003-09-04
EE200200314A (et) 2003-08-15
HUP0301686A2 (hu) 2003-08-28
IS6417A (is) 2002-06-12
NO20022870D0 (no) 2002-06-14
BG106816A (en) 2003-04-30
PL356032A1 (pl) 2004-06-14

Similar Documents

Publication Publication Date Title
AU4114201A (en) Cyclic compounds
IL148291A0 (en) Aromatic nitrogen-containing 6-membered cyclic compounds
GB2357761B (en) Compounds
IL135488A0 (en) Cyclic amine derivatives
PL356032A1 (pl) Czwartorzędowe cykliczne związki amonowe
EG24350A (en) Prilling method
GB2355714B (en) Ammonium 3,5-diaminopicrate
GB9904930D0 (en) Thiazoloindolinone compounds
GB9712882D0 (en) Quaternary ammonium compounds
GB9902399D0 (en) Compounds
PL344240A1 (en) Stabilised quaternary ammonium compositions
DE59904818D1 (de) Quartäre Ammoniumverbindungen
DE69925119D1 (de) Stabilisierte quaternäre ammoniumzusammensetzungen
GB9929433D0 (en) Cyclic compound
GB9922446D0 (en) Amine compounds
TW433360U (en) Double-core structure for multiple-sectional lock
TW421073U (en) Improved structure for twisting-twisting cycles
AUPP671098A0 (en) Active quaternary ammonium compounds
TW463788U (en) Improved structure for cap
GB9903243D0 (en) Compounds
GB9901429D0 (en) Compounds
GB9903266D0 (en) Compounds
GB9903420D0 (en) Compounds
GB9903296D0 (en) Compounds
GB9903268D0 (en) Compounds